Experimental cell transplantation for myocardial repair

Handbook of Cardiac Anatomy, Physiology, and Devices

Volumn , Issue , 2005, Pages 427-438

  Lee, Joseph ^a   Asakura, Atsushi ^b   Zhang, Jianyi ^b  

^a University of Minnesota   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876933360     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59259-835-9_31     Document Type: Chapter

References (124)

1. Kajstura, J., Leri, A., Finato, N., Di Loreto, C., Beltrami, C.A., and Anversa, P. (1998) Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA. 95, 8801-8805.
2. Soonpaa, M.H. and Field, L.J. (1998) Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res. 83, 15-26.
3. Beltrami, A.P., Urbanek, K., Kajstura, J., et al. (2001) Evidence that human cardiac myocytes divide after myocardial infarction. N Eng! JMed. 344, 1750-1757.
4. Urbanek, K., Quaini, F., Tasca, G., et al. (2003) Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci USA. 100, 10,440-10,445.
5. Hirschi, K.K. and Goodell, M.A. (2002) Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells. Gene Ther. 9, 648-652.
6. Jensen, G.S. and Drapeau, C. (2002) The use of in situ bone marrow stem cells for the treatment of various degenerative diseases. Med Hypotheses. 59, 422-428.
7. Ballas, C.B., Zielske, S.P., and Gerson, S.L. (2002) Adult bone marrow stem cells for cell and gene therapies: implications for greater use.,1 Cell Biochem Suppl. 38, 20-28.
8. Laflamme, M.A., Myerson, D., Saffitz, J.E. and Murry, C.E. (2002) Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res. 90, 634-640.
9. Oh, H,, Bradfute, S.B., Gallardo, T.D., et al. (2003). Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. ProcNatlAcadSci USA. 100, 12,313-12,318.
10. Beltrami, A.P., Barlucchi, L., Torella, D., et al. (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 114, 763-776.
11. US Department of Health and Human Services. (2001) Stem Cells: Scientific Progress and Future Research Directions. Available at Website: (http://itpapers.zdnet.com/abstract.aspx?dtid=2&ucid =7&docid=22796). Accessed 15 September 2004.
12. Reffelmann, T., Leor, J., Muller-Ehmsen, J., Kedes, L., and Kloner, R.A. (2003) Cardiomyocyte transplantation into the failing heartnew therapeutic approach for heart failure? Heart Fail Rev. 8, 201-211.
13. Caplice, N.M. and Gersh, B.J. (2003) Stem cells to repair the heart: a clinical perspective. Circ Res. 92, 6-8.
14. Leor, J., Patterson, M., Quinones, M.J., Kedes, L.H., and Kloner, R.A. (1996) Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium? Circulation. 94, II332-I1336.
15. Scorsin, M., Marotte, F., Sabri, A., et al. (1996) Can grafted cardiomyocytes colonize peri-infarct myocardial areas? Circulation. 94, 11337-11340.
16. Li, R.K., Jia, Z.Q., Weisel, R.D., et al. (1996) Cardiomyocyte transplantation improves heart function. Ann Thorac Surg. 62,654-660; discussion 660-661.
17. Reinecke, H., Zhang, M., Bartosek, T., and Murry, C.E. (1999) Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation. 100, 193-202.
18. Etzion, S., Battler, A., Barbash, I.M., et al. (2001) Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J Mol Cell Cardiol. 33, 1321-1330.
19. Li, R.K., Mickle, D.A., Weisel, R.D., et al. (1997) Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation. 96, 11179-II186; discussion 186-187.
20. Connold, A.L., Frischknecht, R., Dimitrakos, M., and Vrbova, G. (1997) The survival of embryonic cardiomyocytes transplanted into damaged host rat myocardium. JMuscle Res Cell Motil. 18, 63-70.
21. Matsushita, T., Oyamada, M., Kurata, H., et al. (1999) Formation of cell junctions between grafted and host cardiomyocytes at the border zone of rat myocardial infarction. Circulation. 100, 11262-11268.
22. Soonpaa, M.H., Koh, G.Y., Klug, M.G., and Field, L.J. (1994) Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science. 264, 98-101.
23. Muller-Ehmsen, J., Peterson, K.L., Kedes, L., et al. (2002) Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation. 105, 1720-1726.
24. Scorsin, M., Hagege, A.A., Marotte, F., et al. (1997) Does transplantation of cardiomyocytes improve function of infarcted myocardium? Circulation. 96, II 188-II193.
25. Muller-Ehmsen, J., Whittaker, P., Kloner, R.A., et al. (2002) Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol. 34, 107-116.
26. Zhang, M., Methot, D., Poppa, V., Fujio, Y., Walsh, K., and Murry, C.E. (2001) Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol. 33,907-921.
27. Jennings, R.B. and Reimer, K.A. (1981) Lethal myocardial ischemic injury. Am J Pathol. 102, 241-255.
28. Wada, M.R., Inagawa-Ogashiwa, M., Shimizu, S., Yasumoto, S., and Hashimoto, N. (2002) Generation of different fates from multipotent muscle stem cells. Development. 129, 2987-2995.
29. Asakura, A., Komaki, M., and Rudnicki, M. (2001) Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation. 68,245-253
30. Ghostine, S., Carrion, C., Souza, L.C., et al. (2002) Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation. 106, I 131-1136.
31. Reinecke, H., MacDonald, G.H., Hauschka, S.D., and Murry, C.E. (2000) Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J Cell Biol. 149, 731-740.
32. Rajnoch, C., Chachques, J.C., Berrebi, A., Bruneval, P., Benoit, M.O., and Carpentier, A. (2001) Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg. 121,871-878.
33. Jain, M., DerSimonian, H., Brenner, D.A., et al. (2001 ) Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation. 103, 1920-1927.
34. Taylor, D.A., Atkins, B.Z., Hungspreugs, P., et al. (1998) Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med. 4, 929-933.
35. Zhang, F., Chen, Y., Yang, Z., et al. (2003) Cellular cardiomyoplasty for a patient with heart failure. Cardiovasc Radiat Med. 4, 43-46.
36. Menasche, P., Hagege, A.A., Vilquin, J.T., et al. (2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coil Cardiol. 41, 1078-1083.
37. Hagege, A.A., Carrion, C., Menasche, P., et al. (2003) Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet. 361,491-492.
38. Menasche P. (2003) Myoblast-based cell transplantation. HeartFail Rev. 8,221-227.
39. Jin, H., Yang, R., Li, W., et al. (2003) Early treatment with hepatocyte growth factor improves cardiac function in experimental heart failure induced by myocardial infarction. J Pharmacol Exp Ther. 304, 654-660.
40. Kitta, K., Day, R.M., Kim, Y., Torregroza, I., Evans, T., and Suzuki, Y.J. (2003) Hepatocyte growth factor induces GATA-4 phosphorylation and cell survival in cardiac muscle cells. J Biol Chem. 278, 4705-4712.
41. Miyagawa, S., Sawa, Y., Taketani, S., et al. (2002) Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty. Circulation. 105, 2556-2561.
42. Takayama, H., LaRochelle, W.J., Sharp, R., et al. (1997) Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci USA. 94, 701-706.
43. van der Voort, R., Taher, T,E., Derksen, P.W., Spaargaren, M., van der Neut, R., and Pals, S.T. (2000) The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation. Adv Cancer Res. 79, 39-90.
44. Reyes, M., Lund, T., Lenvik, T., Aguiar, D., Koodie, L. and Verfaillie, C.M. (2001) Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 98, 2615-2625.
45. Jiang, Y., Jahagirdar, B.N., Reinhardt, R.L., et al. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 418, 41-49.
46. Thomson, J.A., ltskovitz-Eldor, J., Shapiro, S.S., et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science. 282, 1145-1147.
47. Shamblott, M.J., Axelman, J., Wang, S., et al. (1998) Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA. 95, 13,726-13,731.
48. Williams, R.L., Hilton, D.J., Pease, S., et al. (1988) Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature. 336, 684-687.
49. Orkin, S.H. (1998) Embryonic stem cells and transgenic mice in the study of hematopoiesis, lnt J Dev Biol. 42, 927-934.
50. Weissman, I.L. (2000) Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science. 287, 1442-1446.
51. Gage, F.H. (2000) Mammalian neural stem cells. Science. 287, 1433-1438.
52. Svendsen, C.N., Caldwell, M.A., and Ostenfeld, T. (1999) Human neural stem cells: isolation, expansion and transplantation. Brain Pathol. 9,499-513.
53. Okabe, S., Forsberg-Nilsson, K., Spiro, A.C., Segal, M. and McKay, R.D. (1996) Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro. Mech Dev. 59, 89-102.
54. Potten, C.S. (1998) Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philos Trans R Soc Lond B Biol Sci. 353,821-830.
55. Watt, F.M. (1998) Epidermal stem cells: markers, patterning and the control of stem cell fate. Philos Trans R Soc Lond B Biol Sci. 353, 831-837.
56. Alison, M. and Sarraf, C. (1998) Hepatic stem cells. JHepatol. 29, 676-682.
57. Haynesworth, S.E., Baber, M.A. and Caplan, A.I. (1992) Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone. 13, 69-80.
58. Pittenger, M.F., Mackay, A.M., Beck, S.C., et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science. 284, 143-147.
59. Gronthos, S., Zannettino, A.C., Graves, S.E., Ohta, S., Hay, S.J. and Simmons, P.J. (1999) Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells. JBone MinerRes. 14, 47-56.
60. Prockop, D.J. (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 276, 71-74.
61. Asakura, A. and Rudnicki, M.A. (2002) Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation. Exp Hematol. 30, 1339-1345.
62. Asakura, A., Seale, P., Girgis-Gabardo, A., and Rudnicki, M.A. (2002) Myogenic specification of side population cells in skeletal muscle. J Cell Biol. 159, 123-134.
63. Szmitko, P.E., Fedak, P.W., Weisel, R.D., Stewart, D.J., Kutryk, M.J., and Verma, S. (2003) Endothelial progenitor cells: new hope for a broken heart. Circulation. 107, 3093-3100.
64. Forrester, J.S., Price, M.J., and Makkar, R.R. (2003) Stem cell repair of infarcted myocardium: an overview for clinicians. Circulation. 108, 1139-1145.
65. Reubinoff, B.E., Pera, M.F., Fong, C.Y., Trounson, A., and Bongso, A. (2000) Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol. 18, 399-404.
66. Mitalipova, M., Calhoun, J., Shin, S., et al. (2003) Human embryonic stem cell lines derived from discarded embryos. Stem Cells. 21,521-526.
67. Xu, C., Police, S., Rao, N,, and Carpenter, M.K. (2002) Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res. 91,501-508.
68. Kehat, I., Kenyagin-Karsenti, D., Snir, M., et al. (2001) Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest. 108,407-414.
69. Mummery, C., Ward-van Oostwaard, D., Doevendans, P., et al. (2003) Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation. 107, 2733-2740.
70. Kehat, I., Gepstein, A., Spira, A., Itskovitz-Eldor, J., and Gepstein, L. (2002) High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel in vitro model for the study of conduction. Circ Res. 91,659-661.
71. Vanderlaan, R.D., Oudit, G.Y., and Backx, P.H. (2003) Electrophysiological profiling of cardiomyocytes in embryonic bodies derived from human embryonic stem cells: therapeutic implications. Circ Res. 93, 1-3.
72. Fijnvandraat, A.C., van Ginneken, A.C., de Boer, P.A., et al. (2003) Cardiomyocytes derived from embryonic stem cells resemble cardiomyocytes of the embryonic heart tube. Cardiovasc Res. 58, 399-409.
73. Klug, M.G., Soonpaa, M.H., Koh, G.Y., and Field, L.J. (1996) Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest. 98, 216-224.
74. Bradley, J.A., Bolton, E.M., and Pedersen, R.A. (2002) Stem cell medicine encounters the immune system. Nat Rev lmmunol. 2, 859-871.
75. Friedenstein, A.J. (1976) Precursor cells of mechanocytes. Int Rev Cytol. 47,327-359.
76. Caplan, A.I. (1991 ) Mesenchymal stem cells. J Orthop Res. 9, 641-650.
77. Goodell, M.A., Brose, K., Paradis, G., Conner, A.S., and Mulligan, R.C. (1996) Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 183, 1797-1806.
78. Chiu, R.C. (2003) Bone-marrow stem cells as a source for cell therapy. Heart Fail Rev. 8,247-251.
79. Jackson, K.A., Majka, S.M., Wang, H., et al. (2001) Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin hvest. 107, 1395-1402.
80. Tomita, S., Li, R.K., Weisel, R.D., et al. (1999) Autologous transplantation of bone marrow cells improves damaged heart function. Circulation. 100, II247-II256.
81. Orlic, D., Kajstura, J., Chimenti, S., et al. (2001) Bone marrow cells regenerate infarcted myocardium. Nature. 410, 701-705.
82. Wang, J.S., Shum-Tim, D., Galipeau, J., Chedrawy, E., Eliopoulos, N., and Chiu, R.C. (2000) Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg. 120, 999-1005.
83. Wang, J.S., Shum-Tim, D., Chedrawy, E., and Chiu, R.C. (2001) The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. J Thorac Cardiovasc Surg. 122, 699-705.
84. Tomita, S., Nakatani, T., Fukuhara, S., Morisaki, T., Yutani, C., and Kitamura, S. (2002) Bone marrow stromal cells contract synchronously with cardiomyocytes in a coculture system. Jpn J Thorac Cardiovasc Surg. 50, 321-324.
85. Saito, T., Kuang, J.Q., Bittira, B., A1-Kbaldi, A., and Chiu, R.C. (2002) Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann Thorac Surg. 74, 19-24.
86. Liechty, K.W., MacKenzie, T.C., Shaaban, A.F., et al. (2000) Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med. 6, 1282-1286.
87. Orlic, D., Kajstura, J., Chimenti, S., Bodine, D.M., Leri, A., and Anversa, P. (2001) Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci. 938, 221-229; discussion 229-230.
88. Haynesworth, S.E., Goshima, J., Goldberg, V.M., and Caplan, A.I. (1992) Characterization of cells with osteogenic potential from human marrow. Bone. 13, 81-88.
89. Mangi, A.A., Noiseux, N., Kong, D., et al. (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med. 9, 1195-1201.
90. Shake, J.G., Gruber, P.J., Baumgartner, W.A., et al. (2002) Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg. 73, 1919-1925; discussion 1926.
91. Toma, C., Pittenger, M.F., Cahill, K.S., Byrne, B.J., and Kessler, P.D. (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 105, 93-98.
92. Liu, J., Hu, Q., Mansoor, A., et al. (2003) Autologous mesenchymal stem cell in myocardial infarction. Paper presented at American Heart Association Scientific Sessions 2003, Orlando, FL, November 9-11.
93. Wang, X., Liu, J., Hu, Q., et al. (2003) Relationships between contractile function and increased neovascularization in hearts with patch based autologous stem cell transplantation. Paper presented at American Heart Association Scientific Sessions 2003, Orlando, FL, November 9-11.
94. Stamm, C., Westphal, B., Kleine, H.D., et al. (2003) Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet. 361, 45-46.
95. Tse, H.F., Kwong, Y.L., Chan, J.K., Lo, G., Ho, C.L., and Lau, C.P. (2003) Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet. 361, 47-49.
96. Strauer, B.E., Brehm, M., Zeus, T., et al. (2002) Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 106, 1913-1918.
97. Assmus, B., Schachinger, V., Teupe, C., et al. (2002) Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation. 106, 3009-3017.
98. Wagers, A.J., Sherwood, R.I., Christensen, J.L., and Weissman, I.L. (2002) Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 297, 2256-2259.
99. Gussoni, E., Soneoka, Y., Strickland, C.D., et al. (1999) Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 401,390-394.
100. Majka, S.M., Jackson, K.A., Kienstra, K.A., Majesky, M.W., Goodell, M.A., and Hirschi, K.K. (2003) Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration. J Clin Invest. 111, 71-79.
101. Welm, B.E., Tepera, S.B., Venezia, T., Graubert, T.A., Rosen, J.M., and Goodell, M.A. (2002) Sca-l(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol. 245, 42-56.
102. Hierlihy, A.M., Seale, P., Lobe, C.G., Rudnicki, M.A., and Megeney, L.A. (2002) The post-natal heart contains a myocardial stem cell population. FEBS Lett. 530, 239-243.
103. Asakura, A. (2003) Stem cells in adult skeletal muscle. Trends Cardiovasc Med. 13, 123-128.
104. Jiang, Y., Vaessen, B., Lenvik, T., Blackstad, M., Reyes, M., and Verfaillie, C.M. (2002) Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol. 30, 896-904.
105. Rogers, I. and Casper, R.F. (2003) Stem cells: you can't tell a cell by its cover. Hum Reprod Update. 9, 25-33.
106. Erices, A., Conget, P., and Minguell, J.J. (2000) Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 109, 235-242.
107. Rocha, V., Wagner, J.E., Jr., Sobocinski, K.A., et al. (2000) Graftversus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med. 342, 1846-1854.
108. Fibbe, W.E. and Noort, W.A. (2003) Mesenchymal stem cells and hematopoietic stem cell transplantation. Ann N Y Acad Sci. 996, 235-244.
109. Makino, S., Fukuda, K., Miyoshi, S., et al. (1999) Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest. 103,697-705.
110. Hakuno, D., Fukuda, K., Makino, S., et al. (2002) Bone marrowderived regenerated cardiomyocytes (CMG cells) express functional adrenergic and muscarinic receptors. Circulation. 105, 380-386.
111. Lattanzi, L., Salvatori, G., Coletta, M., et al. (1998) High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies. J Clin Invest. 101, 2119-2128.
112. Etzion, S., Barbash, I.M., Feinberg, M.S., et al. (2002) Cellular cardiomyoplasty of cardiac fibroblasts by adenoviral delivery of MyoD ex vivo: an unlimited source of cells for myocardial repair. Circulation. 106, I125-I130.
113. Campbell, K.H., McWhir, J., Ritchie, W.A., and Wilmut, I. (1996) Sheep cloned by nuclear transfer from a cultured cell line. Nature. 380, 64-66.
114. Lanza, R.P., Chung, H.Y., Yoo, J.J., et al. (2002) Generation of histocompatible tissues using nuclear transplantation. Nat Biotechnol. 20, 689-696.
115. Yau, T.M., Fung, K., Weisel, R.D., Fujii, T., Mickle, D.A., and Li, R.K. (2001) Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation. 104, I218-1222.
116. Schwarz, E.R., Speakman, M.T., Patterson, M., et al. (2000) Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat-angiogenesis and angioma formation. J Am Coll Cardiol. 35, 1323-1330.
117. Lee, R.J., Springer, M.L., Blanco-Bose, W.E., Shaw, R., Ursell, P.C., and Blau, H.M. (2000) VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation. 102, 898-901.
118. Iguchi, A., Kobayashi, R., Yoshida, M., et al. (2001) Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation. Bone Marrow Transplant. 27, 1173-1180.
119. Lee, M., Rentz, J., Bikram, M., Han, S., Bull, D.A., and Kim, S.W. (2003) Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer. Gene Ther. 10, 1535-1542.
120. Donahue, J.K., Heldman, A.W., Fraser, H., et al. (2000) Focal modification of electrical conduction in the heart by viral gene transfer. Nat Med. 6, 1395-1398.
121. Feld, Y., Melamed-Frank, M., Kehat, I., Tal, D., Marom, S., and Gepstein, L. (2002) Electrophysiological modulation of cardiomyocytic tissue by transfected fibroblasts expressing potassium channels: a novel strategy to manipulate excitability. Circulation. 105,522-529.
122. Miake, J., Marban, E., and Nuss, H.B. (2002) Biological pacemaker created by gene transfer. Nature. 419, 132-133.
123. Suzuki, K., Murtuza, B., Sammut, I.A., et al. (2002) Heat shock protein 72 enhances manganese superoxide dismutase activity during myocardial ischemia-reperfusion injury, associated with mitochondrial protection and apoptosis reduction. Circulation. 106, I270-I276.
124. Suzuki, K., Murtuza, B., Smolenski, R.T., et al. (2001) Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation. 104, I308-I313.